Melatonin semizlikni davolashda yordamchi vosita sifatida: metabolik sindromli bemor ayolning klinik holati

This article examines the relationship between melatonin levels and obesity through a clinical case. Melatonin, a hormone that regulates the sleep–wake cycle, has become an object of scientific interest due to its influence on metabolism and its possible involvement in the mechanisms underlying obesity development. In the presented case, a patient with class I obesity was found to have a low nocturnal melatonin level, which may have contributed to insulin resistance and metabolic disturbances. The article analyzes the patient’s melatonin level and its association with body fat and muscle mass percentages, and also discusses possible lifestyle modification recommendations aimed at improving the metabolic profile. The need for further research is emphasized in order to better understand the role of melatonin in the pathophysiology of obesity and to develop effective treatment strategies. This clinical case illustrates how melatonin deficiency may be associated with unfavorable changes in body weight and highlights the importance of a comprehensive approach to the diagnosis and treatment of obesity.

Hali tarjima qilinmagan